173 related articles for article (PubMed ID: 16753284)
1. Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic era.
Basu A; Meltzer HY
Schizophr Res; 2006 Sep; 86(1-3):99-109. PubMed ID: 16753284
[TBL] [Abstract][Full Text] [Related]
2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of diabetes and antipsychotic prescription patterns in patients with schizophrenia: a nationwide retrospective cohort study.
Okumura Y; Ito H; Kobayashi M; Mayahara K; Matsumoto Y; Hirakawa J
Schizophr Res; 2010 Jun; 119(1-3):145-52. PubMed ID: 20304611
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.
Cohen D; Dekker JJ; Peen J; Gispen-de Wied CC
Eur Neuropsychopharmacol; 2006 Apr; 16(3):187-94. PubMed ID: 16263247
[TBL] [Abstract][Full Text] [Related]
5. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.
Fleischhacker WW; Siu CO; Bodén R; Pappadopulos E; Karayal ON; Kahn RS;
Int J Neuropsychopharmacol; 2013 Jun; 16(5):987-95. PubMed ID: 23253821
[TBL] [Abstract][Full Text] [Related]
6. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
Jerrell JM; McIntyre RS; Tripathi A
Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
[TBL] [Abstract][Full Text] [Related]
7. Altered metabolic parameters in association with antipsychotic medication use in diabetes: A population based case-control study.
Wake DJ; Broughton P; Perera SM; MacIntyre DJ; Leese GP
Psychoneuroendocrinology; 2016 Apr; 66():214-20. PubMed ID: 26849203
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore.
Shafie S; Lee SP; Ong SBC; Wang P; Seow E; Ong HL; Chong SA; Subramaniam M
Singapore Med J; 2018 Sep; 59(9):465-471. PubMed ID: 29430576
[TBL] [Abstract][Full Text] [Related]
9. Diabetes, tardive dyskinesia, parkinsonism, and akathisia in schizophrenia: a retrospective study applying 1998 diabetes health care guidelines to antipsychotic use.
Lévy E; Margolese HC; Annable L; Chouinard G
Can J Psychiatry; 2004 Jun; 49(6):398-402. PubMed ID: 15283536
[TBL] [Abstract][Full Text] [Related]
10. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
Touré JT; Brandt NJ; Limcangco MR; Briesacher BA
Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618
[TBL] [Abstract][Full Text] [Related]
11. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study.
Bai YM; Chen TT; Yang WS; Chi YC; Lin CC; Liou YJ; Wang YC; Su TP; Chou P; Chen JY
Schizophr Res; 2009 Jun; 111(1-3):1-8. PubMed ID: 19409756
[TBL] [Abstract][Full Text] [Related]
12. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review.
De Hert M; Schreurs V; Sweers K; Van Eyck D; Hanssens L; Sinko S; Wampers M; Scheen A; Peuskens J; van Winkel R
Schizophr Res; 2008 Apr; 101(1-3):295-303. PubMed ID: 18299188
[TBL] [Abstract][Full Text] [Related]
13. Serum free Fatty acids and glucose metabolism, insulin resistance in schizophrenia with chronic antipsychotics.
Wang CJ; Zhang ZJ; Sun J; Zhang XB; Mou XD; Zhang XR; Shang XF; Zhang TQ
Biol Psychiatry; 2006 Dec; 60(12):1309-13. PubMed ID: 16650386
[TBL] [Abstract][Full Text] [Related]
14. Second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia: an observational pharmacoepidemiology study from 1988 to 2002.
Reist C; Mintz J; Albers LJ; Jamal MM; Szabo S; Ozdemir V
J Clin Psychopharmacol; 2007 Feb; 27(1):46-51. PubMed ID: 17224711
[TBL] [Abstract][Full Text] [Related]
15. Association Between Antipsychotic Treatment and Advanced Diabetes Complications Among Schizophrenia Patients With Type 2 Diabetes Mellitus.
Wu CS; Gau SS
Schizophr Bull; 2016 May; 42(3):703-11. PubMed ID: 26721264
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus in patients with schizophrenia in Taiwan.
Hung CF; Wu CK; Lin PY
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):523-7. PubMed ID: 15866353
[TBL] [Abstract][Full Text] [Related]
17. Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databases.
Scalone L; Cesana G; Furneri G; Ciampichini R; Beck-Peccoz P; Chiodini V; Mangioni S; Orsi E; Fornari C; Mantovani LG
PLoS One; 2014; 9(12):e113741. PubMed ID: 25470484
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus in patients with schizophrenia in West-Bank, Palestine.
Sweileh WM; Dalal SA; Zyoud SH; Al-Jabi SW; Al-Ali I
Diabetes Res Clin Pract; 2013 Mar; 99(3):351-7. PubMed ID: 23369226
[TBL] [Abstract][Full Text] [Related]
19. Diabetes prevalence estimates in schizophrenia and risk factor assessment.
Argo T; Carnahan R; Barnett M; Holman TL; Perry PJ
Ann Clin Psychiatry; 2011 May; 23(2):117-24. PubMed ID: 21547272
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus onset in geriatric patients: does long-term atypical antipsychotic exposure increase risk?
Abitbol R; Rej S; Segal M; Looper KJ
Psychogeriatrics; 2015 Mar; 15(1):43-50. PubMed ID: 25369990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
